EuCorVac-19 is a COVID-19 vaccine candidate developed by EuBiologics Co. EuBiologics Co., Ltd started the study on February 23, 2021. The study is titled... 4 KB (260 words) - 19:08, 13 February 2024 |
be approved for the general population. For example, the CoronaVac, Covishield, BBIBP-CorV and Covaxin vaccines are not part of Australia's national vaccination... 318 KB (19,351 words) - 20:00, 21 April 2024 |
 | 26 July 2021. "Safety, Tolerance and Immunogenicity of EuCorVac-19 for the Prevention of COVID-19 in Healthy Adults". ClinicalTrials.gov. 5 March 2021.... 98 KB (20,593 words) - 02:58, 8 March 2024 |
 | 000 participants. BBIBP-CorV shares similar technology with CoronaVac and Covaxin, other inactivated virus vaccines for COVID-19. Its product name is SARS-CoV-2... 90 KB (8,570 words) - 16:40, 27 January 2024 |
 | COVID-19 vaccination in South Korea is an ongoing immunization campaign against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus... 17 KB (1,133 words) - 00:27, 5 March 2024 |
The COVID-19 pandemic in Nepal is part of the worldwide pandemic of coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2... 181 KB (23,901 words) - 14:23, 6 January 2024 |
 | Sinopharm (company) (category COVID-19 vaccine producers) 000 participants. BBIBP-CorV shares similar technology with CoronaVac and BBV152, other inactivated virus vaccines for COVID-19. Peer-reviewed results... 17 KB (1,205 words) - 14:53, 8 November 2023 |
Sinopharm Group (section COVID-19 Vaccine development) BIBP COVID-19 vaccine, also known as BBIBP-CorV, the Sinopharm COVID-19 vaccine, or BIBP vaccine, is one of two inactivated virus COVID-19 vaccines developed... 13 KB (885 words) - 16:13, 18 April 2024 |
| SARS-CoV-2 Beta variant (redirect from 501.V2 COVID-19) variant, (B.1.351), was a variant of SARS-CoV-2, the virus that causes COVID-19. One of several SARS-CoV-2 variants initially believed to be of particular... 72 KB (6,070 words) - 06:39, 3 February 2024 |
| SARS-CoV-2 Delta variant (redirect from Indian COVID-19 strain) Ranasinghe, Thushali; Dayarathne, Shashika (19 July 2021). "Antibody and T cell responses to Sinopharm/BBIBP-CorV in naive and previously infected individuals... 101 KB (10,984 words) - 22:09, 17 October 2023 |
 | second is CoronaVac from China. On 1 November 2021, the TGA recognised two more vaccines: Covaxin and the Sinopharm BIBP vaccine (BBIBP-CorV). On 17 January... 178 KB (12,119 words) - 03:08, 8 March 2024 |
dictionary Jonathan Slocum, Indo-European Lexicon from the University of Texas Linguistic Research Center IE-CoR (Indo-European Cognate Relationships)... 337 KB (8,973 words) - 19:43, 21 April 2024 |
programul la Liga 4" [The League 4 schedule has been set]. informatiadeseverin.eu. Archived from the original on 21 December 2022. Retrieved 26 September 2022... 508 KB (9,597 words) - 17:11, 6 April 2024 |